Futura Medical plc is a pharmaceutical group that develops innovative products for the consumer healthcare market.
Our business strategy is centered on selecting and developing products with regard to four elements:
- Return on Investment: we focus on consumer healthcare products that offer the potential for a significant return on the costs of development.
- Over-The-Counter: our aim is to produce safe and effective over-the-counter products which are available to consumers on a general retail basis or through chemists without the need for a doctor's prescription.
- Strong Intellectual Property: we develop and retain commercially valuable intellectual property including know-how, patents and trademarks
- Licensing: we aim to license our products during their development to established distributors who offer the best potential commercial opportunities
The Group's activities have been funded by a combination of share issues, research and development tax credits, interest and government grants. As at 31 December 2007, share issues totalled £14.5 million net of costs. As at 31 December 2007, other funding sources have contributed a further £1.2 million.